Hong Kong Communications Stock News

China Shineway Pharmaceutical Group's (HKG:2877) stock is up by a considerable 17% over the past three months. As most...

Dongfang Electric's (HKG:1072) stock is up by a considerable 53% over the past three months. Given that stock prices...

Those holding Jolimark Holdings Limited ( HKG:2028 ) shares would be relieved that the share price has rebounded 35% in...

Success Dragon International Holdings' (HKG:1182) stock is up by a considerable 32% over the past three months. Given...

Key Insights Insiders appear to have a vested interest in Z Fin's growth, as seen by their sizeable ownership Yaping Ou...

CSPC Pharmaceutical Group recently reported that its aldosterone synthase inhibitor SYH2072 secured U.S. FDA and China NMPA approvals to begin clinical trials for uncontrolled and resistant hypertension, while its fixed-dose Prusogliptin and Metformin Extended-Release diabetes therapy application was accepted by China’s NMPA. These parallel advances in hypertension and type 2 diabetes programs highlight CSPC’s push into higher-value, patent-protected treatments across major chronic disease...

Why this new collaboration matters for CARsgen Therapeutics Holdings (SEHK:2171) CARsgen Therapeutics Holdings (SEHK:2171) just announced a clinical collaboration with Dispatch Bio to run a Phase 1 trial in China, testing a combined approach for treating solid tumors using both companies' immunotherapies. The study, planned to begin in 2026, will evaluate DISP-11, which uses Dispatch's Flare platform and DV-10 tumor specific virus together with CARsgen's zevorcabtagene autoleucel, or zevor...

Despite an already strong run, Weichai Power Co., Ltd. ( HKG:2338 ) shares have been powering on, with a gain of 26% in...

Key Insights Insiders appear to have a vested interest in Tesson Holdings' growth, as seen by their sizeable ownership...

The Winshine Science Company Limited ( HKG:209 ) share price has done very well over the last month, posting an...

For many, the main point of investing is to generate higher returns than the overall market. But the main game is to...

The Chengdu SIWI Science and Technology Company Limited ( HKG:1202 ) share price has done very well over the last...

As Asia's markets navigate a complex landscape of regulatory changes and economic shifts, investors are increasingly focused on opportunities that provide stable returns amidst volatility. In this environment, dividend stocks stand out for their potential to deliver consistent income, making them an attractive option for those looking to balance growth prospects with reliable payouts.

With a price-to-sales (or "P/S") ratio of 0.3x Lerado Financial Group Company Limited ( HKG:1225 ) may be sending very...

Unfortunately for some shareholders, the EverChina Int'l Holdings Company Limited ( HKG:202 ) share price has dived 26...

China Resources Beer (Holdings) (HKG:291) has had a rough month with its share price down 4.8%. However, a closer look...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Public...

If you want to compound wealth in the stock market, you can do so by buying an index fund. But one can do better than...

As Asian markets navigate a complex landscape of regulatory changes and economic shifts, investors are increasingly focused on identifying stocks that may be priced below their intrinsic value. In this environment, a good stock is often characterized by strong fundamentals and resilience to market fluctuations, making it an attractive option for those seeking potential opportunities in undervalued equities.

Alco Holdings Limited ( HKG:328 ) shares have had a really impressive month, gaining 49% after a shaky period...

With a price-to-earnings (or "P/E") ratio of 9.8x Yankuang Energy Group Company Limited ( HKG:1171 ) may be sending...

Grand Pharmaceutical Group recently reported that China’s NMPA accepted its New Drug Application for TLX591-CDx (Illuccix®, gallium Ga 68 PSMA-11) for prostate cancer diagnosis, following positive Phase III data showing a 94.8% positive predictive value in Chinese patients with biochemically recurrent disease. Alongside this, the company outlined a broad push in nuclear medicine, with multiple Y-90 liver cancer indications cleared in the US and Europe and several radiopharmaceuticals...

Huaneng Power International, Inc. recently reported preliminary consolidated electricity sales for the fourth quarter and full year 2025, with power plants in the PRC selling 106.112 billion kWh in the quarter and 437.563 billion kWh for the year, both showing year-on-year declines. The annual sales decrease of 3.39% highlights a meaningful pullback in electricity demand or utilization across the company’s Chinese fleet, raising questions about underlying operating conditions. We will now...

Mongolian Mining Corporation released unaudited operational results for the quarter ended 31 December 2025, reporting higher run-of-mine coal output and increased washed coking coal production versus a year earlier. The company also reported full-year growth in washed coking coal sales volumes and continued to advance its copper-silver-gold project pipeline in Mongolia, underscoring a broader resource portfolio. We will now examine how higher washed coking coal sales and progress in...